文献速递系统性红斑狼疮

系统性红斑狼疮患者的复发:频率、类型与时间的前瞻性队列研究

Flares in patients with systemic lupus erythematosus.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究从英国9个中心招募100例符合BILAG-2004复发标准且需增加免疫抑制的SLE患者,每月评估共9个月。在781次月度评估中,76例患者共发生195次复发,复发率为0.25次/患者月;1个月时22%的患者出现复发,7个月时22%出现严重复发,任何复发的中位时间为4个月。中重度复发倾向于累及基线受累系统。

要点

  • SLE患者复发率为0.25次/患者月,中位复发时间4个月。
  • 1个月时22%出现复发,7个月时22%出现严重复发。
  • 中重度复发多累及基线受累系统,轻度复发可累及任何系统。

核心结论

  • 在活动性SLE人群中,随访早期即出现持续复发,中重度复发源于疾病未能完全控制。

研究设计与样本

  • 前瞻性队列研究,从英国9个中心招募100例符合BILAG-2004复发标准且需增加免疫抑制的SLE患者,基线及每月评估共9个月。

主要发现

  • 94%为女性,61%为白种人,平均年龄40.7岁(s.d. 12.7),平均病程9.3年(s.d. 8.1)。
  • 76例患者共发生195次复发,总评估781次月度,复发率0.25次/患者月。
  • 复发类型包括37次严重、32次中度和126次轻度。
  • 1个月时22%出现轻度/中度/重度复发,7个月时22%出现严重复发。
  • 任何A或B系统复发的中位时间为4个月。

关键数值与推荐

  • 复发定义:严重为任何A系统受累(不论B系统复发数量),中度为两个或以上B系统无A系统,轻度为一个B系统。

临床怎么用

  • 该真实世界数据提示当前治疗下SLE复发常见且早期出现,可用于参考以指导未来临床试验设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: SLE is characterized by relapses and remissions. We aimed to describe the frequency, type and time to flare in a cohort of SLE patients. METHODS: SLE patients with one or more 'A' or 'B' BILAG-2004 systems meeting flare criteria ('new' or 'worse' items) and requiring an increase in immunosuppression were recruited from nine UK centres and assessed at baseline and monthly for 9 months. Subsequent flares were defined as: severe (any 'A' irrespective of number of 'B' flares), moderate (two or more 'B' without any 'A' flares) and mild (one 'B'). RESULTS: Of the 100 patients, 94% were female, 61% White Caucasians, mean age (s.d.) was 40.7 years (12.7) and mean disease duration (s.d.) was 9.3 years (8.1). A total of 195 flares re-occurred in 76 patients over 781 monthly assessments (flare rate of 0.25/patient-month). There were 37 severe flares, 32 moderate flares and 126 mild flares. By 1 month, 22% had a mild/moderate/severe flare and 22% had a severe flare by 7 months. The median time to any 'A' or 'B' flare was 4 months. Severe/moderate flares tended to be in the system(s) affected at baseline, whereas mild flares could affect any system. CONCLUSION: . In a population with active SLE we observed an ongoing rate of flares from early in the follow-up period with moderate-severe flares being due to an inability to fully control the disease. This real-world population study demonstrates the limitations of current treatments and provides a useful reference population from which to inform future clinical trial design.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. McElhone K, Abbott J, Hurley M, et al. Flares in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2021. PMID: 33325488. doi:10.1093/rheumatology/keaa777

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。